Literature DB >> 8437011

Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside.

H J Willison1, J Veitch, G Paterson, P G Kennedy.   

Abstract

A recent report described serum anti-GQ1b ganglioside antibodies in Miller Fisher syndrome (MFS), a clinical variant of Guillain-Barré syndrome (GBS). Four consecutive cases of MFS all had high titre anti-GQ1b antibodies which were absent from all control sera including those of patients with GBS.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8437011      PMCID: PMC1014824          DOI: 10.1136/jnnp.56.2.204

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  6 in total

1.  An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia).

Authors:  M FISHER
Journal:  N Engl J Med       Date:  1956-07-12       Impact factor: 91.245

2.  Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome.

Authors:  A Chiba; S Kusunoki; T Shimizu; I Kanazawa
Journal:  Ann Neurol       Date:  1992-06       Impact factor: 10.422

3.  Gangliosides of peripheral nerve myelin.

Authors:  J W Fong; R W Ledeen; S K Kundu; S W Brostoff
Journal:  J Neurochem       Date:  1976-01       Impact factor: 5.372

4.  Acute axonal polyneuropathy associated with anti-GM1 antibodies following Campylobacter enteritis.

Authors:  N Yuki; H Yoshino; S Sato; T Miyatake
Journal:  Neurology       Date:  1990-12       Impact factor: 9.910

5.  Acute motor neuropathy with antibodies to GM1 ganglioside.

Authors:  N A Gregson; D Jones; P K Thomas; H J Willison
Journal:  J Neurol       Date:  1991-12       Impact factor: 4.849

Review 6.  Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system.

Authors:  R H Quarles; A A Ilyas; H J Willison
Journal:  Chem Phys Lipids       Date:  1986-12-15       Impact factor: 3.329

  6 in total
  37 in total

Review 1.  Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy.

Authors:  C Caudie
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

Review 2.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

3.  Bickerstaff's encephalitis and the Miller Fisher syndrome.

Authors:  J B Winer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-10       Impact factor: 10.154

4.  Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infection.

Authors:  B Schwerer; A Neisser; H Bernheimer
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

5.  Serum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndrome.

Authors:  A Neisser; H Bernheimer; T Berger; A P Moran; B Schwerer
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Miller Fisher syndrome in infancy.

Authors:  J Benito-León; J Bravo; F Mateos; R Simón
Journal:  Childs Nerv Syst       Date:  1996-09       Impact factor: 1.475

Review 7.  Autoimmune responses in peripheral nerve.

Authors:  H P Hartung; H Willison; S Jung; M Pette; K V Toyka; G Giegerich
Journal:  Springer Semin Immunopathol       Date:  1996

Review 8.  Guillain-Barré syndrome. Clinical manifestations and directions for treatment.

Authors:  J Rees
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

9.  Anti-GQ1b ganglioside antibody and ophthalmoplegia of undetermined cause.

Authors:  T Suzuki; A Chiba; S Kusunoki; M Chikuda; T Fujita; K Misu
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

10.  Peripheral neuropathy associated with monoclonal IgM anti-Pr2 cold agglutinins.

Authors:  H J Willison; G Paterson; J Veitch; G Inglis; S C Barnett
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.